1Shah-Khan M, Boughey JC. Evolution of axillary nodal stag- ing in breast cancer: clinical implications of the ACOSOG Z0011 trial[J]. Cancer Control,2012,19(4) :267-276.
3Knauer M, Konstant~niuk P, Haid A, et aL Multicentric- breast cancer~ a new indication for sentinel node biopsy- amulti-institutional validation study [J]. J Clin Oncol, 2006,24(21) ..3374-3480.
6Johnson S, Arora S, Babu E. Injecting patent blue dye V for sentinel lymph node biopsy without skin staining[J]. Ann R Coil Surg Engl,2012,94(4) :277-278.
7Aliakbarian M, Memar B,Jangjoo A,et al. Factors influ-eneing the time of sentinel node visualization in breast cancer patients using intradermal injection of the radio- tracer[J]. Am J Surg,2011,202(2) : 199-202.
8Meretoja TJ, Joensuu H, Heikkila PS. Safety of sentinel node biopsy in breast cancer patients who receive a sec- ond radioisotope injection after visualization failure in lymphoscintigraphy[J]. J Surg Oncol, 2010,102 (6) : 649- 6,q.q.
6Fleissig A,Fallowfield LJ,Langridge CI,et al.Post-operative arm morbidity and quality of life.Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer[J].Breast Cancer Res Treat,2006; 95(3):279-293.
7Veronesi U,Paganelli G,Viale G,et al.A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer[J].N Engl J Med,2003; 349(6):546-553.
8Julian TB,Krag D,Brown A,et al.Preliminary technical results of NSABP B-32,a randomized phase Ⅲ clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients[J].Breast Cancer Res Treat,2004; 88(Suppl 1):s11-s12.
9Helyer LK,Coburn NG,Law CH,et al.Axillary staging is more accurate today than ever before:no increase in the false negative rate with wide-spread adoption of sentinel node technique[J].Breast Cancer Res Treat,2007; 106(Suppl 1):s127-s128.
10Filippakis GM,Zografos G.Contraindications of sentinel lymph node biopsy:are there any really?[J].World J Surg Oncol,2007; 5(1):10-20.
6Penn CL,Kathy Webb.Longtime advocate fights her own battle with breast cancer[J].J Ark Med Soc,2014,111(5):80-81.
7Ishikawa T,Saski T,Tanabe M,et al.The Pathological Response to Anthracycline is Associated with Topoisomerase IIalpha Gene Amplification in the HER2 Breast Cancer Subset[J].J Surg Sci,2014,2(1):10-12.
